Literature DB >> 18679125

Impaired plasma B-type natriuretic peptide clearance in human septic shock.

Romain Pirracchio1, Nicolas Deye, Anne Claire Lukaszewicz, Alexandre Mebazaa, Bernard Cholley, Joaquim Matéo, Bruno Mégarbane, Jean Marie Launay, Jacqueline Peynet, Frédéric Baud, Didier Payen.   

Abstract

INTRODUCTION: High B-type natriuretic peptide (BNP) levels are reported in the context of septic shock. We hypothesized that high BNP levels might be related to an alteration in BNP clearance pathway, namely neutral endopeptidase (NEP) 24.11. NEP 24.11 activity was measured in septic shock and in cardiogenic shock patients. We further evaluated whether baseline plasma BNP can predict fluid responsiveness and whether BNP can still be released in plasma despite high initial BNP levels, in response to overloading.
MATERIAL AND METHODS: Prospective observational study. Patients in severe sepsis (S) or in septic shock (SS) needing a fluid challenge were included. Stroke volume (SV) and BNP were measured before (SV1, BNP1) and 45 mins after (SV2, BNP2) a standardized fluid challenge. DeltaBNP was defined as the difference between BNP2 and BNP1. NEP 24.11 activity was determined by fluorometry in 12 SS and 4 S patients before fluid challenge and in 5 cardiogenic shock patients.
RESULTS: Twenty-three patients (61 +/- 18 years old, Simplified Acute Physiology Score II: 54 +/- 21; 19 SS, 4 S; BNP1: 1371 +/- 1434 pg/mL) were studied. BNP1 concentrations were significantly higher in SS than in S (1643 +/- 1437 vs. 80 +/- 35 pg/mL; p = 0.002). There was no correlation between baseline BNP and fluid responsiveness. Nine of the 11 patients with BNP1 >1000 pg/mL were fluid responders. DeltaBNP was greater in fluid nonresponders than in fluid responders (22 +/- 27% vs. 6 +/- 11%, p = 0.028). Plasma BNP was higher in SS than in cardiogenic shock patients (1367 +/- 1438 vs. 750 +/- 346 respectively; p = 0.027). NEP 24.11 activity was lower in SS than in S patients (0.10 +/- 0.06 nmole/mL/min vs. 0.50 +/- 0.22 nmole/mL/min, p <0.0001) cardiogenic shock patients (0.10 +/- 0.06 nmole/mL/min vs. 0.58 +/- 0.19 nmole/mL/min; p = 0.002).
CONCLUSION: High levels of BNP might be related to an alteration in BNP clearance. During sepsis, high BNP levels are not predictive of fluid nonresponsiveness. Nevertheless, in fluid nonresponders, acute ventricular stretching can result in further BNP release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679125     DOI: 10.1097/CCM.0b013e318183f067

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

Review 1.  [Cardiac biomarkers in the critically ill].

Authors:  S Reith; N Marx
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-01-06       Impact factor: 0.840

2.  [Sepsis and heart].

Authors:  H Ebelt; K Werdan
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

3.  Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.

Authors:  Yann-Erick Claessens; Thierry Mathevon; Gérald Kierzek; Sophie Grabar; David Jegou; Eric Batard; Clarisse Loyer; Alain Davido; Pierre Hausfater; Hélène Robert; Leila Lavagna-Perez; Bruno Bernot; Patrick Plaisance; Christophe Leroy; Bertrand Renaud
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

Review 4.  Protein O-GlcNAcylation in cardiovascular diseases.

Authors:  Hui-Fang Wang; Yi-Xuan Wang; Yu-Ping Zhou; Yun-Peng Wei; Yi Yan; Ze-Jian Zhang; Zhi-Cheng Jing
Journal:  Acta Pharmacol Sin       Date:  2022-07-11       Impact factor: 7.169

5.  Characterization of critically ill patients with septic shock and sepsis-associated cardiomyopathy using cardiovascular MRI.

Authors:  Fabian Muehlberg; Edyta Blaszczyk; Kerstin Will; Stefan Wilczek; Joerg Brederlau; Jeanette Schulz-Menger
Journal:  ESC Heart Fail       Date:  2022-05-19

6.  Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers.

Authors:  David J Sturgess; Thomas H Marwick; Chris Joyce; Carly Jenkins; Mark Jones; Paul Masci; David Stewart; Bala Venkatesh
Journal:  Crit Care       Date:  2010-03-24       Impact factor: 9.097

7.  Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality.

Authors:  Jiri Parenica; Jan Malaska; Jiri Jarkovsky; Jolana Lipkova; Milan Dastych; Katerina Helanova; Jiri Litzman; Josef Tomandl; Simona Littnerova; Jana Sevcikova; Roman Gal; Pavel Sevcik; Jindrich Spinar; Monika Pavkova Goldbergova
Journal:  Exp Clin Cardiol       Date:  2012

Review 8.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

9.  N-terminal pro-B-type natriuretic peptide for predicting fluid challenge in patients with septic shock.

Authors:  Hui-Bin Huang; Biao Xu; Guang-Yun Liu; Bin Du
Journal:  Ann Transl Med       Date:  2019-06

10.  Expression of neutral endopeptidase activity during clinical and experimental acute lung injury.

Authors:  Soshi Hashimoto; Fumimasa Amaya; Kentaro Oh-Hashi; Kazutoshi Kiuchi; Satoru Hashimoto
Journal:  Respir Res       Date:  2010-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.